Home > Healthcare > Pharmaceuticals > Finished Drug Form > Cancer Biological Therapy Market

Cancer Biological Therapy Market Share

Report ID: GMI676
Published Date: Jan 2023
Report Format: PDF

Download Free Sample

Cancer Biological Therapy Market Share

Some leading companies in the cancer biological therapy market include

AbbVie Inc.
Amgen Inc.
Astellas Pharma Inc.
Bayer AG
Bristol-Myers Squibb Company
Eisai Co., Ltd.
Merck
AstraZeneca
GlaxoSmithKline plc
ELI Lilly and Company
Incyte
Otsuka
Pfizer
Sanofi
F. Hoffmann-La Roche
Novartis
Takeda Pharmaceuticals
Seattle Genetics
Spectrum Pharmaceuticals

These companies are focusing on product innovations to achieve competitive lead.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for cancer biological therapy was worth more than USD 111.5 billion in 2022 and is projected to record over 7% CAGR from 2023-2032.

Blood cell growth factors (BCGF) is estimated to surpass USD 50 billion by 2032 due to increasing use in preventing side effects of cancer treatments.

Europe cancer biological therapy market size is slated to reach over USD 55.5 billion by 2032 led by rising cases of cancer and the surging geriatric population.

AbbVie Inc., Amgen Inc., Bayer AG, Merck, AstraZeneca, Incyte, Otsuka, Pfizer, Sanofi, Novartis, Seattle Genetics are some of the key manufacturers of cancer biological therapy worldwide.